GENIX PHARMACEUTICALS CORP (GENX.CA) Stock Price, Forecast & Analysis

Can you describe the business of GENIX PHARMACEUTICALS CORP?

Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm is a formulator, manufacturer, licensor and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its operations consist primarily of the research, development, manufacture, in-licensing and sales of novel and healthcare products, focusing on proprietary over the counter (OTC) nutraceuticals and generic pharmaceuticals. The firm has been marketing and selling other nutraceuticals and some pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels and spirulina powder. Its products include Ketorolac 0.5% Eye Drops, Timolol 0.5% Eye Drops, Diclofenac 0.1% Eye Drops, Moxifloxacin Hydrochloride 0.5% Eye Drops, Prednisolone Acetate 1% Eye Drops, Olopatadine 0.1% Eye Drops, and others.

Can you provide the latest stock price for GENIX PHARMACEUTICALS CORP?

The current stock price of GENX.CA is 0.025 CAD. The price increased by 25% in the last trading session.

Does GENX stock pay dividends?

GENX.CA does not pay a dividend.

How is the ChartMill rating for GENIX PHARMACEUTICALS CORP?

GENX.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.

Would investing in GENIX PHARMACEUTICALS CORP be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on GENX.CA.

What is the market capitalization of GENX stock?

GENIX PHARMACEUTICALS CORP (GENX.CA) has a market capitalization of 1.53M CAD. This makes GENX.CA a Nano Cap stock.